Technological advancements in the Primary Clostridioides Difficile Infection industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologi
Complete genome sequences of toxigenic Clostridium difficile clinical isolates from patients of Lower Hudson Valley, New York, USA. These genomes will enable a more comprehensive toxigenic evaluation
Lactobacillus casei strain T21 attenuates Clostridioides difficile infection in murine model through attenuation of dysbiosis and inflammation with the enhanced mucin production
